|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A double-blind, place-bocontmlledo randomized phase Ⅲ trial of gemcitabine ( G ) plus bevacizumab(B) versus gemcitabine plus placebo (P)in patients (pts) with advanced pancreatic cancer ( PC ) : A preliminary analysis of Cancer and Leukemia Group B(CALGB) 显示文摘 | Kindler HL Niedzwiecki D Hollis D | 2007 | J Clin Oncol2007，25，18： | 1 |
| 2 | Phase Ⅲ study of irinotecan/5FU/LV (FOLFIRI)or oxaliplatin/5FU/LV (FOLFOX)-+-cetuximab for pa- tients with untreated metastatic adenocarcinoma ofthe colon or rectum (MCRC): CALGB 80203 pre- liminary results显示文摘 | VENOOK A NIEDZWIECKI D HOLLIS D | 2006 | Journal of Clinical Oncology2006，24，18： | 1 |
| 3 | Safety of nifedipine in angina pectoris: a meta - analysis 显示文摘 | Stason WB Schmid CH Niedzwiecki D | 1999 | Hypertension1999，33，1： | 1 |
| 4 | Safety of nifedipine in patients with hypertension: a meta-analysis显示文摘 | Stason WB Schmid CH Niedzwiecki D whiting GW Caubet JF Luo D Ross SD Chalmers TC | 1997 | Hypertension1997，30，11： | 1 |
| 5 | Adjuvant therapy in recter cancer analysis of stage, sex and local control-final report of Intergroup 0114显示文摘 | Tepper JE O'Connell M J Niedzwiecki D | 2002 | J Clin Oncol2002，20，7： | 1 |
| 6 | Irinotecan plus fluorouracil/leucovorin(IFL) versus fluorouracil/leucovorin alone(FL) in stage Ⅲ colon cancer(intergroup trial CALGB C89803)显示文摘 | Saltz LB Niedzwiecki D Hollis D | 2004 | Proc Am Soc Clin Oncol2004，，： | 1 |
| 7 | Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ)adenocarcinoma using epirubicin,cisplatin,and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT:I显示文摘 | Fuchs CS Tepper JE Niedzwiecki D | | 0，，15： | 1 |
| 8 | Hepatic arterial Infusion versus systemic therapy for hepatic metastases from colorectal cancer:a randomized trial of efficacy,quality of life,and molecular markers (CALGB 9481)显示文摘 | Kemeny N Niedzwiecki D Hollis DR | 2006 | J Clin Oncol2006，24，9： | 1 |
| 9 | Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804 显示文摘 | Bartlett NL Niedzwiecki D Johnson JL | 2007 | Ann Oncol2007，18，6： | 1 |
| 10 | Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251显示文摘 | Rizzieri DA Johnson JL Niedzwiecki D | 2004 | Cancer2004，100，7： | 1 |
| 11 | Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal Cancer:a randomized trial of efficacy,quality of Life,and molecular markers(CALGB 9481)显示文摘 | Kemeny NE Niedzwiecki D Hollis DR | 2006 | J Clin Oncol2006，24，： | 1 |
| 12 | Hepatic arterial infusion versus systemic therapy for hepatic metastases from' colorectal Cancer: a randomized trial of efficacy, quality of Life, and molecular markers (CALGB 9481)显示文摘 | Kemeny NE Niedzwiecki D Hollis DR | 2006 | J Clin Oncol2006，24，： | 1 |
| 13 | Hepatic arterial infusion versus systemic therapy for hepatic metastases from eolorectal Cancer: a randomized trial of efficacy, quality of Life, and molecular markers (CALGB 9481)显示文摘 | Kemeny NE Niedzwiecki D Hollis DR | 2006 | J Clin Oncol2006，24，： | 1 |
| 14 | Adu- rant therapy in rectal cancer: analysis of stage, sex, and local control - final report of intergroup 0114显示文摘 | TEPPER J E O'CONNELL M J NIEDZWIECKI D | 2002 | J Clin Oncol2002，20，7： | 1 |
| 15 | CALGB/SWOG 80405:phase Ⅲ trial of irinotecart/5-FU/leucovorin (FOLFIRI)or oxaliplatin/5-FU/qeucovorin (mFOLFOX6) with bevacizumab (RV)or cetuximab(CET)for patients (pts)with KRAS wild-type(wt)untreated metastatic ade- nocarcinoma of the colon or rectum (MCRC) 显示文摘 | Venook AP Niedzwiecki D Lenz H | 2014 | J Clin Oncol2014，32，15： | 1 |
| 16 | Unrelated umbilical cord blood transplantation in adult patients显示文摘 | Gwynn D Long Mary Laughlin Bella Madan Joanne Kurtzberg Cristina Gasparetto Ashley Morris David Rizzieri Clayton Smith James Vredenburgh Edward C Halperin Gloria Broadwater Donna Niedzwiecki Nelson J Chao | 2003 | Biology of Blood and Marrow Transplantation2003，，： | 1 |
| 17 | Phase Ⅲ study of irinotecan/ 5-FU/ LV (FOLFIRI) or oxaliplatin/ 5-FU/ LV (FOLFOX) + cetuximab for patients ( pts ) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC) : CALGB 80203 preliminary results 显示文摘 | VENOOK A NIEDZWIECKI D HOLLIS D | 2006 | J Clin Oncol2006，24，18： | 1 |
| 18 | Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma :final results of Cancer and Leukemia Group B Study 9251显示文摘 | Rizzieri DA Johnson JL Niedzwiecki D | 2004 | Cancer2004，100，7： | 1 |
| 19 | Impact of num- ber of nodes retrieved on outcome in patients with rectal cancer 显示文摘 | Tepper JE O Connell M J Niedzwiecki D | 2001 | J Clin Oncol2001，19，1： | 1 |
| 20 | Phase Ⅰ/Ⅱ study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: cancer and leukemia group B 89901 显示文摘 | Ryan DP Niedzwiecki D Hollis D | 2006 | J Clin Oncol2006，24，16： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员